Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: A pharmaceutical standpoint
Files
Publication date
2016-12
Authors
Ravinetto, Raffaella
De Weggheleire, Anja
Dorlo, Thomas P C
Francque, Sven
Sokkab, An
Pouget, Corinne
Meessen, Bruno
Tabernero, Patricia
Newton, Paul N.
Lynen, Lut
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Access to medicines, Counterfeit medicines, Essential medicines, Hepatitis C, Quality of medicines, Substandard medicines, Taverne, Parasitology, Public Health, Environmental and Occupational Health, Infectious Diseases, SDG 3 - Good Health and Well-being
Citation
Ravinetto, R, De Weggheleire, A, Dorlo, T P C, Francque, S, Sokkab, A, Pouget, C, Meessen, B, Tabernero, P, Newton, P N & Lynen, L 2016, 'Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C : A pharmaceutical standpoint', Tropical Medicine and International Health, pp. 1490-1495. https://doi.org/10.1111/tmi.12784